Bremelanotide's approved label is contraindicated in uncontrolled high blood pressure and in known cardiovascular disease. Tell your provider your blood pressure, your heart history, every medicine and supplement you take, whether you take naltrexone, and whether you are pregnant or breastfeeding.
Nausea, flushing, and headache were the reactions most often reported in bremelanotide trials. The approved label also covers a temporary rise in blood pressure, a fall in heart rate, and darkening of skin in patches. Get urgent care for hives, swelling, trouble breathing, chest tightness, or fainting.
The tablet also contains oxytocin. Headache, nausea, temporary changes in blood pressure, and mood changes are the side effects most often listed for it. Oxytocin can make the uterus contract, so do not use the tablet if you are or could be pregnant.
The FDA-approved bremelanotide product is Vyleesi, a 1.75 mg autoinjector for acquired, generalized hypoactive sexual desire disorder in premenopausal women. Rebody's sublingual tablet is a compounded prescription medication. It is a different product and it does not carry that approval or that indication.
Compounded medications are not FDA-approved or evaluated by the FDA for safety, efficacy, or quality. Prescription treatment requires a provider decision and is not available in every state.